{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:07:57Z","timestamp":1790842077882,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T00:00:00Z","timestamp":1390176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1038\/npp.2014.9","type":"journal-article","created":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T05:52:45Z","timestamp":1390197165000},"page":"1624-1634","source":"Crossref","is-referenced-by-count":126,"title":["Inflammatory and Metabolic Dysregulation and the 2-Year Course of Depressive Disorders in Antidepressant Users"],"prefix":"10.1038","volume":"39","author":[{"given":"Nicole","family":"Vogelzangs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aartjan TF","family":"Beekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianne KB","family":"van Reedt Dortland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Schoevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik J","family":"Giltay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda WJH","family":"Penninx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,20]]},"reference":[{"key":"BFnpp20149_CR1","unstructured":"American Psychiatric Association (2001) Diagnostic and Statistical Manual of Mental Disorders 4th edn American Psychiatric Association: Washington, DC."},{"key":"BFnpp20149_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0304-3940(94)90933-4","volume":"179","author":"WA Banks","year":"1994","unstructured":"Banks WA, Kastin AJ, Gutierrez EG (1994). Penetration of interleukin-6 across the murine blood\u2013brain barrier. Neurosci Lett 179: 53\u201356.","journal-title":"Neurosci Lett"},{"key":"BFnpp20149_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.biopsych.2009.11.004","volume":"67","author":"BT Baune","year":"2010","unstructured":"Baune BT, Dannlowski U, Domschke K, Janssen DG, Jordan MA, Ohrmann P et al (2010). The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression. Biol Psychiatry 67: 543\u2013549.","journal-title":"Biol Psychiatry"},{"key":"BFnpp20149_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1600-0447.2005.00684.x","volume":"113","author":"MA Buist-Bouwman","year":"2006","unstructured":"Buist-Bouwman MA, de GR, Vollebergh WA, Alonso J, Bruffaerts R, Ormel J (2006). Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six European countries. Acta Psychiatr Scand 113: 492\u2013500.","journal-title":"Acta Psychiatr Scand"},{"key":"BFnpp20149_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/npp.2012.191","volume":"38","author":"A Cattaneo","year":"2013","unstructured":"Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison KJ et al (2013). Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal \u2018targets'. Neuropsychopharmacology 38: 377\u2013385.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp20149_CR6","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE et al (2003). International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35: 1381\u20131395.","journal-title":"Med Sci Sports Exerc"},{"key":"BFnpp20149_CR7","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK et al (2010). A meta-analysis of cytokines in major depression. Biol Psychiatry 67: 446\u2013457.","journal-title":"Biol Psychiatry"},{"key":"BFnpp20149_CR8","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1176\/appi.ajp.2011.10081163","volume":"168","author":"HE Duivis","year":"2011","unstructured":"Duivis HE, de JP, Penninx BW, Na BY, Cohen BE, Whooley MA (2011). Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am J Psychiatry 168: 913\u2013920.","journal-title":"Am J Psychiatry"},{"key":"BFnpp20149_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.pnpbp.2007.09.015","volume":"32","author":"T Eller","year":"2008","unstructured":"Eller T, Vasar V, Shlik J, Maron E (2008). Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 32: 445\u2013450.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp20149_CR10","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al (2005). Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735\u20132752.","journal-title":"Circulation"},{"key":"BFnpp20149_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bbi.2010.09.013","volume":"25","author":"M Hamer","year":"2011","unstructured":"Hamer M, Batty GD, Marmot MG, Singh-Manoux A, Kivimaki M (2011). Anti-depressant medication use and C-reactive protein: results from two population-based studies. Brain Behav Immun 25: 168\u2013173.","journal-title":"Brain Behav Immun"},{"key":"BFnpp20149_CR12","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/npp.2011.132","volume":"36","author":"J Hannestad","year":"2011","unstructured":"Hannestad J, DellaGioia N, Bloch M (2011). The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36: 2452\u20132459.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp20149_CR13","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1017\/S0033291712000128","volume":"42","author":"SA Hiles","year":"2012","unstructured":"Hiles SA, Baker AL, de MT, Attia J (2012). Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis. Psychol Med 42: 2015\u20132026.","journal-title":"Psychol Med"},{"key":"BFnpp20149_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71: 171\u2013186.","journal-title":"Psychosom Med"},{"key":"BFnpp20149_CR15","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1001\/archgenpsychiatry.2011.160","volume":"69","author":"RC Kessler","year":"2012","unstructured":"Kessler RC, Avenevoli S, Costello EJ, Georgiades K, Green JG, Gruber MJ et al (2012). Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry 69: 372\u2013380.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp20149_CR16","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/01.psy.0000124755.91880.f4","volume":"66","author":"LS Kinder","year":"2004","unstructured":"Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP (2004). Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 66: 316\u2013322.","journal-title":"Psychosom Med"},{"key":"BFnpp20149_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0165-1781(00)00184-0","volume":"96","author":"M Kubera","year":"2000","unstructured":"Kubera M, Simbirtsev A, Mathison R, Maes M (2000). Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL\/6 mice. Psychiatry Res 96: 255\u2013266.","journal-title":"Psychiatry Res"},{"key":"BFnpp20149_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.comppsych.2011.01.011","volume":"53","author":"F Lamers","year":"2012","unstructured":"Lamers F, Hoogendoorn AW, Smit JH, Van DR, Zitman FG, Nolen WA et al (2012). Sociodemographic and psychiatric determinants of attrition in the Netherlands Study of Depression and Anxiety (NESDA). Compr Psychiatry 53: 63\u201370.","journal-title":"Compr Psychiatry"},{"key":"BFnpp20149_CR19","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/mp.2012.144","volume":"18","author":"F Lamers","year":"2013","unstructured":"Lamers F, Vogelzangs N, Merikangas KR, de JP, Beekman AT, Penninx BW (2013). Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry 18: 692\u2013699.","journal-title":"Mol Psychiatry"},{"key":"BFnpp20149_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","volume":"22","author":"S Lanquillon","year":"2000","unstructured":"Lanquillon S, Krieg JC, ing-Abu-Shach U, Vedder H (2000). Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22: 370\u2013379.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp20149_CR21","first-page":"143","volume":"4","author":"CG Lyketsos","year":"1994","unstructured":"Lyketsos CG, Nestadt G, Cwi J, Heithoff K, Eaton WW (1994). The life chart interview: a standardized method to describe the course of psychopathology. Int J Methods Psychiatric Res 4: 143\u2013155.","journal-title":"Int J Methods Psychiatric Res"},{"key":"BFnpp20149_CR22","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers CD, Loncar D (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442.","journal-title":"PLoS Med"},{"key":"BFnpp20149_CR23","doi-asserted-by":"crossref","unstructured":"Mead GE, Morley W, Campbell P, Greig CA, McMurdo M, Lawlor DA (2009). Exercise for depression. Cochrane Database Syst Rev CD004366.","DOI":"10.1002\/14651858.CD004366.pub4"},{"key":"BFnpp20149_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bbi.2013.04.004","volume":"31","author":"D Mehta","year":"2013","unstructured":"Mehta D, Raison CL, Woolwine BJ, Haroon E, Binder EB, Miller AH et al (2013). Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression. Brain Behav Immun 31: 205\u2013215.","journal-title":"Brain Behav Immun"},{"key":"BFnpp20149_CR25","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL (2009). Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65: 732\u2013741.","journal-title":"Biol Psychiatry"},{"key":"BFnpp20149_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1055\/s-2004-832682","volume":"37","author":"N Muller","year":"2004","unstructured":"Muller N, Riedel M, Schwarz MJ (2004). Psychotropic effects of COX-2 inhibitors\u2014a possible new approach for the treatment of psychiatric disorders. Pharmacopsychiatry 37: 266\u2013269.","journal-title":"Pharmacopsychiatry"},{"key":"BFnpp20149_CR27","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/sj.mp.4001805","volume":"11","author":"N Muller","year":"2006","unstructured":"Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B et al (2006). The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 11: 680\u2013684.","journal-title":"Mol Psychiatry"},{"key":"BFnpp20149_CR28","doi-asserted-by":"publisher","first-page":"622","DOI":"10.2174\/138920008785821738","volume":"9","author":"G Neurauter","year":"2008","unstructured":"Neurauter G, Schrocksnadel K, Scholl-Burgi S, Sperner-Unterweger B, Schubert C, Ledochowski M et al (2008). Chronic immune stimulation correlates with reduced phenylalanine turnover. Curr Drug Metab 9: 622\u2013627.","journal-title":"Curr Drug Metab"},{"key":"BFnpp20149_CR29","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2337\/dc11-2055","volume":"35","author":"A Pan","year":"2012","unstructured":"Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR et al (2012). Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 35: 1171\u20131180.","journal-title":"Diabetes Care"},{"key":"BFnpp20149_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/mpr.256","volume":"17","author":"BW Penninx","year":"2008","unstructured":"Penninx BW, Beekman AT, Smit JH, Zitman FG, Nolen WA, Spinhoven P et al (2008). The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 17: 121\u2013140.","journal-title":"Int J Methods Psychiatr Res"},{"key":"BFnpp20149_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jad.2011.03.027","volume":"133","author":"BW Penninx","year":"2011","unstructured":"Penninx BW, Nolen WA, Lamers F, Zitman FG, Smit JH, Spinhoven P et al (2011). Two-year course of depressive and anxiety disorders: results from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord 133: 76\u201385.","journal-title":"J Affect Disord"},{"key":"BFnpp20149_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000318293","volume":"79","author":"HE Pigott","year":"2010","unstructured":"Pigott HE, Leventhal AM, Alter GS, Boren JJ (2010). Efficacy and effectiveness of antidepressants: current status of research. Psychother Psychosom 79: 267\u2013279.","journal-title":"Psychother Psychosom"},{"key":"BFnpp20149_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/07853890.2010.543921","volume":"44","author":"AJ Pyykkonen","year":"2012","unstructured":"Pyykkonen AJ, Raikkonen K, Tuomi T, Eriksson JG, Groop L, Isomaa B (2012). Association between depressive symptoms and metabolic syndrome is not explained by antidepressant medication: results from the PPP-Botnia Study. Ann Med 44: 279\u2013288.","journal-title":"Ann Med"},{"key":"BFnpp20149_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF et al (2013). A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70: 31\u201341.","journal-title":"JAMA Psychiatry"},{"key":"BFnpp20149_CR35","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/mp.2012.125","volume":"18","author":"CD Rethorst","year":"2013","unstructured":"Rethorst CD, Toups MS, Greer TL, Nakonezny PA, Carmody TJ, Grannemann BD et al (2013). Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Mol Psychiatry 18: 1119\u20131124.","journal-title":"Mol Psychiatry"},{"key":"BFnpp20149_CR36","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jad.2008.10.018","volume":"115","author":"D Rhebergen","year":"2009","unstructured":"Rhebergen D, Beekman AT, Graaf R, Nolen WA, Spijker J, Hoogendijk WJ et al (2009). The three-year naturalistic course of major depressive disorder, dysthymic disorder and double depression. J Affect Disord 115: 450\u2013459.","journal-title":"J Affect Disord"},{"key":"BFnpp20149_CR37","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1192\/bjp.181.3.208","volume":"181","author":"J Spijker","year":"2002","unstructured":"Spijker J, de GR, Bijl RV, Beekman AT, Ormel J, Nolen WA (2002). Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Br J Psychiatry 181: 208\u2013213.","journal-title":"Br J Psychiatry"},{"key":"BFnpp20149_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1089\/met.2004.2.82","volume":"2","author":"JP Sutherland","year":"2004","unstructured":"Sutherland JP, McKinley B, Eckel RH (2004). The metabolic syndrome and inflammation. Metab Syndr Relat Disord 2: 82\u2013104.","journal-title":"Metab Syndr Relat Disord"},{"key":"BFnpp20149_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1600-0447.2010.01565.x","volume":"122","author":"AK van Reedt Dortland","year":"2010","unstructured":"van Reedt Dortland AK, Giltay EJ, van VT, Zitman FG, Penninx BW (2010). Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatr Scand 122: 30\u201339.","journal-title":"Acta Psychiatr Scand"},{"key":"BFnpp20149_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pnpbp.2011.10.001","volume":"36","author":"AK van Reedt Dortland","year":"2012","unstructured":"van Reedt Dortland AK, Giltay EJ, van VT, Zitman FG, Penninx BW (2012). Personality traits and childhood trauma as correlates of metabolic risk factors: the Netherlands Study of Depression and Anxiety (NESDA). Prog Neuropsychopharmacol Biol Psychiatry 36: 85\u201391.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp20149_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1600-0447.2008.01333.x","volume":"120","author":"H Viinamaki","year":"2009","unstructured":"Viinamaki H, Heiskanen T, Lehto SM, Niskanen L, Koivumaa-Honkanen H, Tolmunen T et al (2009). Association of depressive symptoms and metabolic syndrome in men. Acta Psychiatr Scand 120: 23\u201329.","journal-title":"Acta Psychiatr Scand"},{"key":"BFnpp20149_CR42","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4088\/JCP.10m06559","volume":"72","author":"N Vogelzangs","year":"2011","unstructured":"Vogelzangs N, Beekman AT, Boelhouwer IG, Bandinelli S, Milaneschi Y, Ferrucci L et al (2011). Metabolic depression: a chronic depressive subtype? Findings from the InCHIANTI study of older persons. J Clin Psychiatry 72: 598\u2013604.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp20149_CR43","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1038\/tp.2012.8","volume":"2","author":"N Vogelzangs","year":"2012","unstructured":"Vogelzangs N, Duivis HE, Beekman AT, Kluft C, Neuteboom J, Hoogendijk W et al (2012). Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl Psychiatry 2: e79.","journal-title":"Transl Psychiatry"},{"key":"BFnpp20149_CR44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4088\/JCP.08m04743blu","volume":"71","author":"N Vogelzangs","year":"2010","unstructured":"Vogelzangs N, Kritchevsky SB, Beekman AT, Brenes GA, Newman AB, Satterfield S et al (2010). Obesity and onset of significant depressive symptoms: results from a prospective community-based cohort study of older men and women. J Clin Psychiatry 71: 391\u2013399.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp20149_CR45","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology Available at \n                    http:\/\/www.whocc.no\/\n                    \n                   (accessed 1 May 2013)."},{"key":"BFnpp20149_CR46","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/S0889-1591(02)00006-5","volume":"16","author":"B Widner","year":"2002","unstructured":"Widner B, Laich A, Sperner-Unterweger B, Ledochowski M, Fuchs D (2002). Neopterin production, tryptophan degradation, and mental depression\u2014what is the link? Brain Behav Immun 16: 590\u2013595.","journal-title":"Brain Behav Immun"},{"key":"BFnpp20149_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0022-3956(94)90036-1","volume":"28","author":"HU Wittchen","year":"1994","unstructured":"Wittchen HU (1994). Reliability and validity studies of the WHO\u2014Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 28: 57\u201384.","journal-title":"J Psychiatr Res"},{"key":"BFnpp20149_CR48","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1016\/j.orcp.2011.04.007","volume":"5","author":"Q Xu","year":"2011","unstructured":"Xu Q, Anderson D, Lurie-Beck J (2011). The relationship between abdominal obesity and depression in the general population: a systematic review and meta-analysis. Obes Res Clin Pract 5: e267\u2013e278.","journal-title":"Obes Res Clin Pract"},{"key":"BFnpp20149_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11892-008-0003-4","volume":"8","author":"T You","year":"2008","unstructured":"You T, Nicklas BJ (2008). Effects of exercise on adipokines and the metabolic syndrome. Curr Diab Rep 8: 7\u201311.","journal-title":"Curr Diab Rep"},{"key":"BFnpp20149_CR50","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1038\/sj.npp.1300172","volume":"28","author":"YW Yu","year":"2003","unstructured":"Yu YW, Chen TJ, Hong CJ, Chen HM, Tsai SJ (2003). Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology 28: 1182\u20131185.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp20149_CR51","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/sj.npp.1301029","volume":"31","author":"CB Zhu","year":"2006","unstructured":"Zhu CB, Blakely RD, Hewlett WA (2006). The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31: 2121\u20132131.","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp20149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp20149","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp20149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:51:24Z","timestamp":1684439484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp20149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,20]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["BFnpp20149"],"URL":"https:\/\/doi.org\/10.1038\/npp.2014.9","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,20]]}}}